Alberto Ferreira

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

David M. Reid, Jean‐Pierre Devogelaer, Kenneth G. Saag et al. · The Lancet · 2009 · 529 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +12

Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study

Isabelle Koné‐Paut, Helen J. Lachmann, Jasmin Kuemmerle‐Deschner et al. · Arthritis Research & Therapy · 2011 · 134 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis

Eric H. Souied, Pravin U. Dugel, Alberto Ferreira et al. · Ophthalmic Epidemiology · 2016 · 64 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA

Alberto Ferreira, Alexandros Sagkriotis, Melvin Olson et al. · PLoS ONE · 2015 · 57 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

Contemporary Management of Severe Symptomatic Aortic Stenosis

M Eugène, Piotr Duchnowski, Bernard Prendergast et al. · Journal of the American College of Cardiology · 2021 · 53 citations · Full text

Medicine, Cardiology, Surgery +14